Allervax allergy therapeutic: Starting a second Phase II trial in 72 patients

ImmuLogic Pharmaceutical Corp. (IMUL) Product: Allervax allergy therapeutic Indication: Allergy to cats Status: Starting a second Phase II trial in 72 patients, using a model of acute bronchial challe...